13 November 2018

Avantium and BASF in dispute over Synvina

The companies disagree on the timing for the fulfilment of the criteria to invest in the commercial-scale plant for FDCA

Avantium and BASF are in a dispute about the future of their Synvina joint venture. The companies disagree on the timing for the fulfilment of the criteria to invest in the commercial-scale plant for FDCA (furandicarboxylic acid).

After an internal strategic review, BASF has served a notice to Avantium that if the investment criteria are not fulfilled by 5 December 2018, it is entitled under the joint venture agreement to exit from Synvina. BASF asserts that fulfilment of the investment criteria for the reference plant must be assessed in the fourth quarter of 2018, as originally envisaged in the joint venture agreement.

Avantium disagrees with this interpretation of the joint venture agreement. Avantium is convinced that the 2-3 year extension of the PEF pilot phase announced in January 2018 logically necessitates a postponed final assessment.

Avantium and BASF are discussing possibilities for an amicable settlement to this difference of opinion.

Should BASF exit the Synvina joint venture, the IP, people, assets and technology for the production of  FDCA and PEF (polyethylenefuranoate) will return to Avantium, allowing it to investigate alternative routes for commercializing the technology.

“We are surprised by BASF’s position. Synvina is actually ahead of the timeline for resolving the technical challenges that led to the postponement announced in January. The work done to date has strengthened our belief in the YXY technology. We are determined to pursue the commercialization of FDCA and PEF – with or without BASF,” says Avantium CEO Tom van Aken.

Source: Avantium, press release, 2018-10-15.

Supplier

Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email